A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study. The findings could help personalize treatments for colon cancer — the second leading cause of cancer-related deaths in the United States — by identifying patients most likely to benefit from chemotherapy.
Gene signature may improve colon cancer treatment
March 14th, 2010 by Newspublichealth.com
Leave a Reply
Sorry, no posts matched your criteria.